BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 18772934)

  • 1. Variation of cell surface hydrophobicity and biofilm formation among genotypes of Candida albicans and Candida dubliniensis under antifungal treatment.
    Borecká-Melkusová S; Bujdáková H
    Can J Microbiol; 2008 Sep; 54(9):718-24. PubMed ID: 18772934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
    Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
    Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between expression of cell surface hydrophobicity protein 1 (CSH1p) and surface hydrophobicity properties of Candida dubliniensis.
    Hazen KC
    Curr Microbiol; 2004 Jun; 48(6):447-51. PubMed ID: 15170242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of farnesol on Candida dubliniensis biofilm formation and fluconazole resistance.
    Jabra-Rizk MA; Shirtliff M; James C; Meiller T
    FEMS Yeast Res; 2006 Nov; 6(7):1063-73. PubMed ID: 17042756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: in vitro susceptibility of 375 Candida albicans isolates and biofilm production.
    Tortorano AM; Prigitano A; Biraghi E; Viviani MA;
    J Antimicrob Chemother; 2005 Oct; 56(4):777-9. PubMed ID: 16144871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interspecies variation in Candida biofilm formation studied using the Calgary biofilm device.
    Parahitiyawa NB; Samaranayake YH; Samaranayake LP; Ye J; Tsang PW; Cheung BP; Yau JY; Yeung SK
    APMIS; 2006 Apr; 114(4):298-306. PubMed ID: 16689830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic diversity and exoenzyme activities of Candida albicans and Candida dubliniensis isolated from the oral cavity of Brazilian periodontal patients.
    Barros LM; Boriollo MF; Alves AC; Klein MI; Gonçalves RB; Höfling JF
    Arch Oral Biol; 2008 Dec; 53(12):1172-8. PubMed ID: 18672229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of new clinical isolates of Candida albicans and C. dubliniensis in Japan: analysis reveals a new genotype of C. albicans with group I intron.
    Tamura M; Watanabe K; Mikami Y; Yazawa K; Nishimura K
    J Clin Microbiol; 2001 Dec; 39(12):4309-15. PubMed ID: 11724837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida dubliniensis, a new fungal pathogen.
    Gutiérrez J; Morales P; González MA; Quindós G
    J Basic Microbiol; 2002; 42(3):207-27. PubMed ID: 12111748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections.
    Seidler M; Salvenmoser S; Müller FM
    Int J Antimicrob Agents; 2006 Dec; 28(6):568-73. PubMed ID: 17101265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal susceptibility and genotypes of Candida albicans strains from patients with vulvovaginal candidiasis.
    Liu XP; Fan SR; Bai FY; Li J; Liao QP
    Mycoses; 2009 Jan; 52(1):24-8. PubMed ID: 18498300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea.
    McCullough MJ; Clemons KV; Stevens DA
    J Clin Microbiol; 1999 Feb; 37(2):417-21. PubMed ID: 9889231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The relationship between Candida albicans 25S intron genotypes and antifungal susceptibilities].
    Balaban N; Karahan ZC; Mumcuoğlu I; Cayirli A; Kuştimur S
    Mikrobiyol Bul; 2007 Apr; 41(2):245-51. PubMed ID: 17682711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arachidonic acid increases antifungal susceptibility of Candida albicans and Candida dubliniensis.
    Ells R; Kock JL; Van Wyk PW; Botes PJ; Pohl CH
    J Antimicrob Chemother; 2009 Jan; 63(1):124-8. PubMed ID: 18971215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the hydrophobic properties of Candida albicans and Candida dubliniensis.
    Hazen KC; Wu JG; Masuoka J
    Infect Immun; 2001 Feb; 69(2):779-86. PubMed ID: 11159968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesion to denture acrylic surfaces and relative cell-surface hydrophobicity of Candida parapsilosis and Candida albicans.
    Panagoda GJ; Ellepola AN; Samaranayake LP
    APMIS; 1998 Jul; 106(7):736-42. PubMed ID: 9740514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aqueous extract from Neem (Azadirachta indica A. Juss) on hydrophobicity, biofilm formation and adhesion in composite resin by Candida albicans.
    Polaquini SR; Svidzinski TI; Kemmelmeier C; Gasparetto A
    Arch Oral Biol; 2006 Jun; 51(6):482-90. PubMed ID: 16412377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular surface hydrophobicity as an additional phenotypic criterion applied to differentiate strains of Candida albicans and Candida dubliniensis.
    Blanco MT; Sacristán B; Beteta A; Fernández-Calderón MC; Hurtado C; Pérez-Giraldo C; Gómez-García AC
    Diagn Microbiol Infect Dis; 2008 Jan; 60(1):129-31. PubMed ID: 17900846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp.
    Pozzatti P; Scheid LA; Spader TB; Atayde ML; Santurio JM; Alves SH
    Can J Microbiol; 2008 Nov; 54(11):950-6. PubMed ID: 18997851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymol inhibits Candida albicans biofilm formation and mature biofilm.
    Braga PC; Culici M; Alfieri M; Dal Sasso M
    Int J Antimicrob Agents; 2008 May; 31(5):472-7. PubMed ID: 18329858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.